In the periphery, spike-specific CD8+ T cell activation—marked by CD38, GZMB, and T-bet expression—positively correlated with greater clinical severity of hepatitis, and their decline paralleled symptom improvement following immunosuppressive therapy. The gene discussed is CD8A; the disease is hepatitis A virus infection.